The year 2017 was marked by pivotal change for AstraZeneca. At that time, the British-Swedish global pharmaceutical and biopharmaceutical company was undergoing a major cultural shift, transforming its Code of Conduct into a Code of Ethics. 

Learn More
Already a member? Sign in to an existing account.

Jaclyn Jaeger is a freelance contributor to Compliance Week after working for the company for 15 years. She writes on a wide variety of topics, including ethics and compliance, risk management, legal,...